<DOC>
	<DOCNO>NCT02858297</DOCNO>
	<brief_summary>Glucosamine ( GlcN ) N-deacetyl amino sugar derive complete hydrolysis chitosan recently report immunoregulatory capacity anti-inflammatory effect administrate orally osteoarthritis atopic dermatitis therapy . Given Oral lichen planus ( OLP ) T-cell-mediated pathogenesis ; drug seem promising therapeutic option . The investigator compare clinical effectiveness Glucosamine combine two topical corticosteroid regimens topical corticosteroid alone symptomatic OLP investigate therapeutic mechanism examine treatment effect expression inhibitor kappa kinase alpha ( IKKα ) interleukin-8 ( IL-8 ) OLP lesion .</brief_summary>
	<brief_title>Glucosamine Novel Adjunctive Therapy Oral Lichen Planus</brief_title>
	<detailed_description>Thirty patient Erosive Atrophic OLP randomly assign Three equal group receive combination topical steroid ( triamcinolone acetonide 0.1 % ) four time per day ( glucosamine sulfate 500 mg ) orally three time per day 8 week ( Group I ) , combination topical steroid twice daily glucosamine sulfate 500 mg orally three time per day 8 week ( Group II ) , topical steroid alone four time per day 8 week ( Group III ) patient follow another treatment free 4 week observational period . Photographs severe lesion take ( Marker lesion ) patient analyze Total Ulcerative Area ( TUA ) , Total Atrophic Area ( TAA ) , Total Reticular Area ( TRA ) , patient also assess use clinical score ( CS ) visual analogue scale ( VAS ) . Pre-treatment post-treatment specimen immunohistochemically stain detect expression IKKα IL-8 .</detailed_description>
	<mesh_term>Lichen Planus , Oral</mesh_term>
	<mesh_term>Lichen Planus</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Clinically Histologically proven painful Bullous/erosive atrophic form OLP lichenoid lesion Presence systemic condition Smoking Known hypersensitivity severe adverse effect treatment drug ingredient preparation Pregnancy breastfeed History previous treatment potentially effective OLP last 3 month Loss pliability flexibility tissue involve oral lesion lichen planus</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Oral lichen planus</keyword>
	<keyword>Glucosamine</keyword>
	<keyword>IL-8</keyword>
</DOC>